UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Comparative Analysis of the Advances in Scar Reduction: Techniques, Technologies, and Efficacy in Plastic Surgery

Curēus (Palo Alto, CA), 2024-08

2024

Volltextzugriff (PDF)

Advances in Tissue Engineering and Its Future in Regenerative Medicine Compared to Traditional Reconstructive Techniques: A Comparative Analysis

Curēus (Palo Alto, CA), 2024-09

2024

Volltextzugriff (PDF)

A Systematic Review of the Optimal Management of Pediatric Distal Radius Displacement Fractures: Open Reduction and Internal Fixation Versus Cast Placement

Curēus (Palo Alto, CA), 2024-08

2024

Volltextzugriff (PDF)

Advantages and Disadvantages of Reconstructive and Preservation Rhinoplasty: Surgical Techniques, Outcomes, and Future Directions

Curēus (Palo Alto, CA), 2024-09

2024

Volltextzugriff (PDF)

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

Molecular cancer therapeutics, 2009-03, Vol.8 (3), p.582-591

2009

Volltextzugriff (PDF)

Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery

BMJ open respiratory research, 2021-09, Vol.8 (1), p.e000917

2021

Volltextzugriff (PDF)

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells

Molecular cancer therapeutics, 2007-12, Vol.6 (12), p.3169-3179

2007

Volltextzugriff (PDF)

Application of radiomics and artificial intelligence in lung cancer immunotherapy: a guide and hurdles from clinical trials

Journal of cancer metastasis and treatment, 2023-08

2023

Volltextzugriff (PDF)

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

The lancet oncology, 2018-11, Vol.19 (11), p.1468-1479

2018

Volltextzugriff (PDF)

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

The lancet oncology, 2017-09, Vol.18 (9), p.1159-1171

2017

Volltextzugriff (PDF)

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

The lancet oncology, 2018-06, Vol.19 (6), p.799-811

2018

Volltextzugriff (PDF)

Evidence-based healthcare, clinical knowledge and the rise of personalised medicine

Journal of evaluation in clinical practice, 2008-10, Vol.14 (5), p.621-649

2008

Volltextzugriff (PDF)

63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107624, Article 107624

2024

Volltextzugriff (PDF)

85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107646, Article 107646

2024

Volltextzugriff (PDF)

93 Evaluating real-world tepotinib-related toxicity data across five UK cancer units- A case-series

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107654, Article 107654

2024

Volltextzugriff (PDF)

IMPACT OF ANAESTHESIA ON PERIOPERATIVE INFLAMMATION IN PATIENTS UNDERGOING LUNG CANCER RESECTION

Journal of cardiothoracic and vascular anesthesia, 2023-10, Vol.37, p.41-42

2023

Volltextzugriff (PDF)

Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial

Journal of thoracic oncology, 2021-08, Vol.16 (8), p.1369-1378

2021

Volltextzugriff (PDF)

COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease

International journal of molecular medicine, 2021-04, Vol.47 (4), p.1, Article 64

2021

Volltextzugriff (PDF)

In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature

Cancers, 2020-11, Vol.12 (12), p.3499

2020

Volltextzugriff (PDF)

Medicine and evidence: knowledge and action in clinical practice

Journal of evaluation in clinical practice, 2007-08, Vol.13 (4), p.481-503

2007

Volltextzugriff (PDF)

A rare occurrence of biphasic pulmonary blastoma in an elderly male

Anticancer research, 2013-09, Vol.33 (9), p.3911-3915

2013

Volltextzugriff (PDF)

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications

Cancers, 2019-03, Vol.11 (3), p.331

2019

Volltextzugriff (PDF)

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

The lancet oncology, 2005-06, Vol.6 (6), p.383-391

2005

Volltextzugriff (PDF)

Abstract 1208: Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1208-1208

2024

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(120)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A Comparative Analysis of the Advances in Scar Reduction: Techniques, Technologies, and Efficacy in Plastic Surgery

Advances in Tissue Engineering and Its Future in Regenerative Medicine Compared to Traditional Reconstructive Techniques: A Comparative Analysis

A Systematic Review of the Optimal Management of Pediatric Distal Radius Displacement Fractures: Open Reduction and Internal Fixation Versus Cast Placement

Advantages and Disadvantages of Reconstructive and Preservation Rhinoplasty: Surgical Techniques, Outcomes, and Future Directions

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery

The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells

Application of radiomics and artificial intelligence in lung cancer immunotherapy: a guide and hurdles from clinical trials

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

Evidence-based healthcare, clinical knowledge and the rise of personalised medicine

63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience

85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data

93 Evaluating real-world tepotinib-related toxicity data across five UK cancer units- A case-series

IMPACT OF ANAESTHESIA ON PERIOPERATIVE INFLAMMATION IN PATIENTS UNDERGOING LUNG CANCER RESECTION

Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial

COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease

In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature

Medicine and evidence: knowledge and action in clinical practice

A rare occurrence of biphasic pulmonary blastoma in an elderly male

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

Abstract 1208: Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy

Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer

Suchergebnisse filtern